Clinical Trials in Cleveland

Showing 7081-7100 of 15,050 trials

Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer

NCT02961374

This phase II trial studies the side effects of erlotinib hydrochloride and how well it works in reducing duodenal polyp burden in patients with familial adenomatous polyposis at risk of developing colon cancer. Erlotinib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Attenuated Familial Adenomatous PolyposisFamilial Adenomatous Polyposis

National Cancer Institute (NCI)46 participantsStarted Oct 2017

Scottsdale, Arizona, United States • Ann Arbor, Michigan, United States • Rochester, Minnesota, United States +5 more locations

COMPLETED< 1 mile

A Study of Immune Responses to the Virus That Causes COVID-19

NCT04431414

The purpose of this study is to learn more about the acute response to infection with and recovery from the virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Some people know this virus by the name "coronavirus." It can cause the disease called COVID-19. The information gained from the study can be used to help develop better tests for SARS-CoV-2 infection and COVID-19 disease and may help in developing future vaccines, other prevention strategies, and treatments.

SARS-CoV-2COVID-19

COVID-19 Prevention Network953 participantsStarted Jul 2020

Birmingham, Alabama, United States • San Francisco, California, United States • Miami, Florida, United States +49 more locations

Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer

A Study of Immune Responses to the Virus That Causes COVID-19

Find Trials by Condition in Cleveland

Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms

Laparoscopic vs. Robotic Ventral Hernia Repair With IPOM

Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma

A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1

A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer

A Study of FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)

Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis

Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy

Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis

Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue

A Clinical Assessment Study in X-Linked Myotubular Myopathy (XLMTM) Subjects

A Study Evaluating Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Subjects 6 Through 11 Years of Age With Cystic Fibrosis and F/MF Genotypes

Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV

Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients Who Have an Inadequate Response to Eculizumab

A Study of the Communication of Genetic Test Results By Telephone: A Multi-Center Study

Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors

A Trial of NOV-205 in Hepatitis C Patients Who Failed Standard Therapy

Prone Positioning Short-term Effects on Tissue Oxygen Saturation in Critical COVID-19 Patients